Relationship of Cardiovascular Risk Factors and Serum Ferritin with C-reactive Protein

Archives of Medical Research

Volumn 38, Issue 1, 2007, Pages 121-125

  Sung, Ki Chul ^a   Kang, Jin Ho ^a   Shin, Hun Sub ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

C reactive protein; Cardiovascular diseases; Risk factors; Serum iron

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FERRITIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; MALE; OXIDATION; RISK FACTOR; SOUTH KOREA;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, LDL; FEMALE; FERRITINS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 33845389103     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2006.08.008     Document Type: Article

References (21)

1. Zheng H., Cable R., Spencer B., Votto N., and Katz S.D. Iron stores and vascular function in voluntary blood donors. Arterioscler Thromb Vasc Biol 25 (2005) 1577-1583
2. van Haelst P.L., van Doormaal J.J., Asselbergs F.W., van Roon A.M., Veeger N.J., Henneman M.M., et al. Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia. Clin Sci Lond 104 (2003) 627-632
3. Sullivan J.L. Iron and the sex difference in heart disease risk. Lancet 1 (1981) 1293-1294
4. Sullivan J.L. The iron paradigm of ischemic heart disease. Am Heart J 117 (1989) 1177-1188
5. Day S.M., Duquaine D., Mundada L.V., Menon R.G., Khan B.V., Rajagopalan S., et al. Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation 107 (2003) 2601-2606
6. Salonen J.T., Nyyssonen K., Korpela H., Tuomilehto J., Seppanen R., and Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86 (1992) 803-811
7. Kiechl S., Willeit J., Egger G., Poewe W., and Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 96 (1997) 3300-3307
8. Ryan T.P., and Aust S.D. The role of iron in oxygen-mediated toxicities. Crit Rev Toxicol 22 (1992) 119-141
9. Williams M.J., Poulton R., and Williams S. Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. Atherosclerosis 165 (2002) 179-184
10. Koenig W., Lowel H., Baumert J., and Meisinger C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 109 (2004) 1349-1353
11. Luc G., Bard J.M., Juhan-Vague I., Ferrieres J., Evans A., Amouyel P., et al. PRIME Study Group, C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study. Arterioscler Thromb Vasc Biol 23 (2003) 1255-1261
12. Rhee E.J., Kim Y.C., Lee W.Y., Jung C.H., Sung K.C., Ryu S.H., et al. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans. Metabolism 55 (2006) 183-187
13. Sung K.C., Suh J.Y., Kim B.S., Kang J.H., Kim H., Lee M.H., et al. High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens 16 (2003) 429-433
14. Magnusson M.K., Sigfusson N., Sigvaldason H., Johannesson G.M., Magnusson S., and Thorgeirsson G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 89 (1994) 102-108
15. Berge L.N., Bonaa K.H., and Nordoy A. Serum ferritin, sex hormones, and cardiovascular risk factors in healthy women. Arterioscler Thromb 14 (1994) 857-861
16. Third Report of the National Cholesterol Education ProgramNCEP. Expert Panel on the Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Adult Treatment Panel III (2002), National Institutes of Health, Washington DC
17. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., et al. Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
18. Lagrand W.K., Visser C.A., Hermens W.T., Niessen H.W., Verheugt F.W., Wolbink G.J., et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon. Circulation 100 (1999) 96-102
19. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565
20. Mainous III A.G., Wells B.J., Everett C.J., Gill J.M., and King D.E. Association of ferritin and lipids with C-reactive protein. Am J Cardiol 93 (2004) 559-562
21. Iribarren C., Sempos C.T., Eckfeldt J.H., and Folsom A.R. Lack of association between ferritin level and measures of LDL oxidation: The ARIC Study. Atherosclerosis 139 (1998) 189-195